Ectopic expression of target genes may represent an inherent limitation of RT-PCR assays used for micrometastasis detection: Studies on the epithelial glycoprotein gene EGP-2

International Journal of Cancer

Volumn 72, Issue 1, 1997, Pages 191-196

  De Graaf, Hiltje ^a   Mælandsmo, Gunhild M ^b   Ruud, Paal ^b   Forus, Anne ^b   Øyjord, Tove ^b   Fodstad, Øystein ^b   Hovig, Eivind ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; METASTASIS; MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ADOLESCENT; ADULT; ANTIGENS, NEOPLASM; CARCINOMA; CELL ADHESION MOLECULES; HUMANS; MIDDLE AGED; MONOCYTES; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-DIRECTED DNA POLYMERASE; TUMOR CELLS, CULTURED;

EID: 0030850028     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970703)72:1<191::AID-IJC27>3.0.CO;2-L     Document Type: Article

References (40)

1. AAMDAL, S., FODSTAD, Ø., KAALHUS, O. and PIHL, A., Chemosensitivity profiles of human cancers assessed by the 6-day SRC assay on serially xenografted tumours. Int. J. Cancer, 37, 579-587 (1986).
2. BEISKE, K., MYKLEBUST, A.T., AAMDAL, S., LANOHOLM, R., JAKOBSEN, E. and FODSTAD, Ø., Detection of bone marrow metastases in small cell lung cancer patients. Comparison of immunologic and morphologic methods. Amer. J. Pathol., 141, 531-538 (1992).
3. BERGER, U., BETTELHEIM, R., MANSI, J.L., EASTON, D. and COOMBES, R.C., The relationship between micrometastases in the bone marrow, histopathologic features of the primary tumor in breast cancer and prognosis. Amer. J. clin. Pathol., 90, 1-6 (1988).
4. BERGSAGEL, P.L., VICTOR-KOBRIN, C., TIMBLIN, C.R., TREPEL, J. and KUEHL, W.M., A murine cDNA encodes a pan-epithelial glycoprotein that is also expressed on plasma cells. J. Immunol., 148, 590-596 (1992).
5. BOYD, M.R. and PAULL, K.D., Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Dev. Res., 34,91-109 (1995).
6. BRUGGER, W., BROSS, K.J., GLATT, M., WEBER, F., MERTELSMANN, R. and KANZ, L., Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood, 83, 636-640 (1994).
7. CHELLY, J., CONCORDET, J.P., KAPLAN, J.C. and KAHN, A., Illegitimate transcription: transcription of any gene in any cell type. Proc. nat. Acad. Sci. (Wash.), 86, 2617-2621 (1989).
8. COOPER, D.N., BERG, L.P., KAKKAR, V.V. and REISS, J., Ectopic (illegitimate) transcription: new possibilities for the analysis and diagnosis of human genetic disease. Ann. Med., 26, 9-14 (1994).
9. COTE, R.J. and ROSEN, P.P., Monoclonal antibodies detect occult breast carcinoma metastases in the bone marrow of patients with early stage disease. Amer. J. surg. Pathol., 12, 333-340 (1988).
10. COTE, R.J., ROSEN, P.P., LESSER, M.L., OLD, L.J. and OSBORNE, M.P., Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J. clin. Oncol., 9, 1749-1756 (1991).
11. DATTA, Y.H., ADAMS, P.T., DROBYSKI, W.R., ETHIER, S.P., TERRY, V.H. and ROTH, M.S., Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J. clin. Oncol, 12, 475-482 (1994).
12. DE GRAAF, H., MULDER, N.H., WILLEMSE, P.H., VAN DER GRAAF, W.T., SLEIJFER, D.T., ZIJLSTRA, J.G., ELIAS, M., SIBINGA, C.T., VELLENGA, E. and DE VRIES, E.G., The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease. Anticancer Res., 15, 2851-2856 (1995).
13. DE LEU, L., HELRICH, W., STEIN, R. and MATTES, M.J., SCLC-cluster-2 antibodies detect the pancarcinoma/epithelial glycoprotein EGP-2. Int. J. Cancer. (Suppl. 8) 60-63 (1994).
14. DE LEIJ, L., POSTMUS, P., POPPEMA, S., ELEMA, J. and THE, T., Lung cancer: basic and clinical aspects, p. 31, M. Nijhoff, Boston (1986).
15. DE VRIES, E.G., DE GRAAF, H., BOONSTRA, A., VAN DER GRAAF, W.T. and MULDER, N.H., High-dose chemotherapy with stem cell reinfusion and growth factor support for solid tumors. Stem Cells, 13, 597-606 (1995).
16. EELES, R.A., WARREN, W. and STAMPS, A., The PCR revolution. Europ. J. Cancer, 28,289-293 (1992).
17. FODSTAD, Ø., Immunomagnetic method for detection of tumor cells in peripheral blood and bone marrow. In: G. Riethmüller, G. Schlimok, J.G. Gribben, K. Pantel, C. Coombes, Ø. Fodstad and B. Windle (eds.). Proceedings from a symposium on micrometastatic disease: clinical significance and detection of tumor cells in blood and bone marrow, pp. 59-66, Pharmacia and Upjohn, Lund, Sweden (1996).
18. FODSTAD, Ø., AAMDAL, S., MCMENAMIN. M., NESLAND, J. and PIHL, A., A new experimental metastasis model in athymic nude mice, the human malignant melanoma LOX. Int. J. Cancer, 41, 442-449 (1988).
19. FODSTAD, Ø., BRØGGER, A., BRULAND, S.Ø., SOLHEIM, O.P., NESLAND, J.M. and PIHL, A., Characteristics of a cell line established from a patient with osteosarcoma, appearing 13 years after treatment for bilateral retinoblastoma. Int. J. Cancer, 38, 33-40 (1986).
20. FODSTAD, Ø., HØIFØDT, H.K., RYE, P.D., TRONES, G.E. and BEISKE, K., New immunobead techniques for sensitive detection of malignant cells in blood and bone marrow. Proc. Amer. Assoc. Cancer Res., 37, 214 (1996).
21. GERHARD, M., JUHL, H., KALTHOFF, H., SCHREIBER, H.W., WAGENER, C. and NEUMAIER, M., Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J. clin. Oncol., 12, 725-729 (1994).
22. GHOSSEIN, R.A., SCHER, H.I., GERALD, W.L., KELLY, W.K., CURLEY, T., AMSTERDAM, A., ZHANG, Z.F. and ROSAI, J., Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. J. clin. Oncol., 13, 1195-1200 (1995).
23. GILLILAND, G., PERRIN, S., BLANCHARD, K. and BUNN, H.F., Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc. nat. Acad. Sci. (Wash.), 87, 2725-2729 (1990).
24. GÖTTLINGER, H.G., FUNKE, I., JOHNSON, J.P., GOKEL, J.M. and RIETHMÜLLER, G., The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy: its biochemical nature, tissue distribution and recognition by different monoclonal antibodies. Int. J. Cancer, 38, 47-53 (1986).
25. HARDINGHAM, J.E., KOTASEK, D., FARMER, B., BUTLER, R.N., Mi, J.X., SAGE, R.E. and DOBROVIC, A., Immunobead-PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction. Cancer Res., 53, 3455-3458 (1993).
26. LlNNENBACH, A.J., SENG, B.A., Wu, S., ROBBINS, S., SCOLLON, M., PYRC, J.J., DRUCK, T. and HUEBNER, K., Retroposition in a family of carcinoma-associated antigen genes. Mol. cell. Biol., 13, 1507-1515 (1993).
27. MYKLEBUST, A.T., BEISKE, K., PHARO, A., DAVIES, C.D.L., AAMDAL, S. and FODSTAD, Ø., Selection of anti-SCLC antibodies for diagnosis of bone marrow metastasis. Brit J. Cancer, 63 (Suppl. 14), 49-53 (1993).
28. OSBORNE, M.P., ASINA, S., WONG, G.Y., OLD. L.J. and COTE. R.J., Immunofluorescent monoclonal antibody detection of breast cancer in bone marrow: sensitivity in a model system. Cancer Res., 49, 2510-2513 (1989).
29. PANTEL, K., Detection of minimal disease in patients with solid tumors. J. Hematother., 5, 359-367 (1996).
30. PEREZ, M.S. and WALKER, L.E., Isolation and characterization of a cDNA encoding the KS1/4 epithelial carcinoma marker. J. Immunol., 142, 3662-3667 (1989).
31. PUNTSCHART, A., JOSTARNDT, K., HOPPELER, H. and BILLETER, R., An efficient polymerase chain reaction approach for the quantitation of multiple RNAs in human tissue samples. PCR Methods Appl., 3, 232-238 (1994).
32. Ross, A.A. and 19 OTHERS, Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood, 82, 2605-2610 (1993).
33. SARKAR, G. and SOMMER, S.S., Access to a messenger RNA sequence or its protein product is not limited by tissue or species specificity. Science, 244, 331-334 (1989).
34. SIMON, B., PODOLSKY, O.K., MOLDENHAUER, G., ISSELBACHER, K.J., GATTONI-CELLI, S. and BRAND, S.J., Epithelial glycoprotein is a member of a family of epithelial cell surface antigens homologous to nidogen, a matrix adhesion protein. Proc. nat. Acad. Sci. (Wash.), 87, 2755-2759 (1990).
35. SMITH, B., SELBY, P., SOUTHGATE, J., PITTMAN, K., BRADLEY, C. and BLAIR, G.E., Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet, 338, 1227-1229 (1991).
36. STRNAD, J., HAMILTON, A.E., BEAVERS, L.S., GAMBOA, G.C., APELGREN, L.D., TABER, L.D., SPORTSMAN, J.R., BUMOL, T.F., SHARP, J.D. and GADSKI, R.A., Molecular cloning and characterization of a human adenocarcinoma/ epithelial cell surface antigen complementary DNA. Cancer Res., 49, 314-317 (1989).
37. SZALA, S., KASAI, Y., STEPLEWSKI, Z., RODECK, U., KOPROWSKI, H. and LINNENBACH, A.J., Molecular cloning of cDNA for the human tumor-associated antigen CO-029 and identification of related transmembrane antigens. Proc. nat. Acad. Sci. (Wash.), 87, 6833-6837 (1990).
38. WANG, A.M., DOYLE, M.V. and MARK, D.F., Quantitation of mRNA by the polymerase chain reaction. Proc. nat. Acad. Sci. (Wash.), 86, 9717-9721 (1989).
39. ZULSTRA, J.G., DE VRIES, E.G. and MULDER, N.H.. Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res., 47, 1780-1784 (1987).
40. ZIMMERMANN, K. and MANNHALTER, J.W., Technical aspects of quantitative competitive PCR. BioTechniques. 21, 268-279 (1996).